Literature DB >> 26265582

Use of faecal occult blood tests in symptomatic patients.

Robert Steele1, Ian Forgacs2, Gwyn McCreanor3, Sally Benton4, Michael Machesney5, Colin Rees2, Stephen P Halloran6, Muti Abulafi7, Deborah Alsina8.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26265582     DOI： 10.1136/bmj.h4256

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  Low-risk bowel cancer symptoms: is it time for FIT?

Authors:  Mazlan Kamarudin
Journal:  Br J Gen Pract       Date:  2019-07       Impact factor: 5.386

2.  The two-week rule colorectal cancer pathway: an update on recent practice, the unsustainable burden on diagnostics and the role of faecal immunochemical testing.

Authors:  W Maclean; R Singh; P Mackenzie; D White; S Benton; J Stebbing; T Rockall; I Jourdan
Journal:  Ann R Coll Surg Engl       Date:  2020-02-21       Impact factor: 1.891

3.  General practitioners' awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers: a national survey.

Authors:  Christian Von Wagner; Sandro Tiziano Stoffel; Madeline Freeman; Helga E Laszlo; Brian D Nicholson; Jessica Sheringham; Dorothy Szinay; Yasemin Hirst
Journal:  BMJ Open       Date:  2019-04-11       Impact factor: 2.692

4.  Experience of adopting faecal immunochemical testing to meet the NICE colorectal cancer referral criteria for low-risk symptomatic primary care patients in Oxfordshire, UK.

Authors:  Brian D Nicholson; Tim James; James E East; David Grimshaw; Maria Paddon; Steve Justice; Jason L Oke; Brian Shine
Journal:  Frontline Gastroenterol       Date:  2018-10-09

5.  Could it be colorectal cancer? General practitioners' use of the faecal occult blood test and decision making--a qualitative study.

Authors:  Cecilia Högberg; Eva Samuelsson; Mikael Lilja; Eva Fhärm
Journal:  BMC Fam Pract       Date:  2015-10-26       Impact factor: 2.497

6.  Variation in Direct Access to Tests to Investigate Cancer: A Survey of English General Practitioners.

Authors:  Brian D Nicholson; Jason L Oke; Peter W Rose; David Mant
Journal:  PLoS One       Date:  2016-07-22       Impact factor: 3.240

Review 7.  Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance.

Authors:  Marie Westwood; Shona Lang; Nigel Armstrong; Sietze van Turenhout; Joaquín Cubiella; Lisa Stirk; Isaac Corro Ramos; Marianne Luyendijk; Remziye Zaim; Jos Kleijnen; Callum G Fraser
Journal:  BMC Med       Date:  2017-10-24       Impact factor: 8.775

8.  Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study.

Authors:  Nigel D'Souza; Theo Georgiou Delisle; Michelle Chen; Sally Benton; Muti Abulafi
Journal:  Gut       Date:  2020-10-21       Impact factor: 23.059
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.